BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1747856)

  • 1. Immunohistochemistry in the diagnosis of malignant melanoma.
    Smoller BR
    Clin Dermatol; 1991; 9(2):235-41. PubMed ID: 1747856
    [No Abstract]   [Full Text] [Related]  

  • 2. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
    Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
    G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of monoclonal antibodies on the study of human malignant melanoma.
    Natali PG; Aguzzi A; Veglia F; Imai K; Burlage RS; Giacomini P; Ferrone S
    J Cutan Pathol; 1983 Dec; 10(6):514-28. PubMed ID: 6198345
    [No Abstract]   [Full Text] [Related]  

  • 4. An immunocytochemical study of malignant melanoma and its differential diagnosis from other malignant tumours.
    Gatter KC; Ralfkiaer E; Skinner J; Brown D; Heryet A; Pulford KA; Hou-Jensen K; Mason DY
    J Clin Pathol; 1985 Dec; 38(12):1353-7. PubMed ID: 3908491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical application of monoclonal antibodies to human malignant melanoma-associated antigens].
    Kageshita T; Ishihara K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1744-8. PubMed ID: 3899015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100 protein and HMB-45 negative "rhabdoid" malignant melanoma: a totally dedifferentiated malignant melanoma?
    Laskin WB; Knittel DR; Frame JN
    Am J Clin Pathol; 1995 Jun; 103(6):772-3. PubMed ID: 7785665
    [No Abstract]   [Full Text] [Related]  

  • 7. A metastatic melanoma with an unusual immunophenotypic profile.
    Gao Z; Stanek A; Chen S
    Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psammomatous malignant melanoma arising in an intradermal naevus.
    Monteagudo C; Ferrández A; González-Devesa M; Llombart-Bosch A
    Histopathology; 2001 Nov; 39(5):493-7. PubMed ID: 11737307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solitary ovarian mass: a case of metastatic malignant melanoma.
    Milicevic S; Bozanovic T; Vilendacic Z; Lazovic G; Kastratovic Kotlica B; Atanackovic J; Bajcetic M
    Eur J Gynaecol Oncol; 2008; 29(1):93-4. PubMed ID: 18386475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunostaining of human melanomas by a monoclonal antibody to B700 mouse melanoma antigen.
    Xu X; Azumi N; Skelton HG; Hearing VJ; Gersten DM
    Eur J Cancer; 1996 Jan; 32A(1):168-73. PubMed ID: 8695227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelanotic bone marrow infiltration secondary to pigmented malignant melanoma.
    Villarrubia J; de Misa RF; Escribano L; Bellas C; Velasco JL
    J Dermatol; 1995 Aug; 22(8):620-2. PubMed ID: 7560463
    [No Abstract]   [Full Text] [Related]  

  • 12. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pitfalls in the clinical application of monoclonal antibodies in malignant melanoma: modulation by and impaired accessibility of antigens to monoclonal antibodies.
    Tilgen W; Matzku S
    Cancer Treat Rev; 1990 Sep; 17(2-3):357-71. PubMed ID: 2272052
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical aid at risk stratification of melanocytic neoplasms.
    Quatresooz P; Arrese JE; Pierard-Franchimont C; Pierard GE
    Int J Oncol; 2004 Jan; 24(1):211-6. PubMed ID: 14654959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A103: An anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues.
    Jungbluth AA; Busam KJ; Gerald WL; Stockert E; Coplan KA; Iversen K; MacGregor DP; Old LJ; Chen YT
    Am J Surg Pathol; 1998 May; 22(5):595-602. PubMed ID: 9591730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma.
    Ordóñez NG; Ji XL; Hickey RC
    Am J Clin Pathol; 1988 Oct; 90(4):385-90. PubMed ID: 2459952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100 protein: a marker for human malignant melanomas?
    Gaynor R; Herschman HR; Irie R; Jones P; Morton D; Cochran A
    Lancet; 1981 Apr; 1(8225):869-71. PubMed ID: 6112296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acral lentiginous nevus.
    Han KH; Cho KH
    J Dermatol; 1998 Jan; 25(1):23-7. PubMed ID: 9519605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KBA.62: a useful marker for primary and metastatic melanomas.
    Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
    Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100, HMB-45, and Melan-A negative primary melanoma.
    Shinohara MM; Deubner H; Argenyi ZB
    Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.